Sign up to save your podcasts
Or
Share Adapting to Progress: Axitinib Intravitreal Implant for Wet AMD
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Adapting to Progress: Axitinib Intravitreal Implant for Wet AMD
David Eichenbaum, MD, will discuss the bioresorbable, hydrogel axitinib intravitreal implant that is under investigation in the SOL-1 phase 3 trial for the treatment of neovascular age-related macular degeneration.
This activity is supported by an independent medical education grant from Ocular Therapeutix.
Click here to view the webinar event, which includes images from the talk.
Want to register with Evolve Medical Education? Click here.
View all episodes
By Evolve Medical Education, LLCDavid Eichenbaum, MD, will discuss the bioresorbable, hydrogel axitinib intravitreal implant that is under investigation in the SOL-1 phase 3 trial for the treatment of neovascular age-related macular degeneration.
This activity is supported by an independent medical education grant from Ocular Therapeutix.
Click here to view the webinar event, which includes images from the talk.
Want to register with Evolve Medical Education? Click here.